Veeva Systems Inc.

VEEV

CIK 0001393052 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$836M
↑+16.0% +$115Mvs FY2025 (Q4)
Operating Income
$246M
↑+30.5% +$57Mvs FY2025 (Q4)
Net Income
$244M
↑+75.8% +$105Mvs FY2025 (Q4)
Gross Profit
$622M
↑+15.3% +$83Mvs FY2025 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
52/100
  • Profitability
    28ROIC 10.7% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 4.89 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    15Asset Turnover 0.39x (1.0+ = capital-efficient)
  • Growth
    70Revenue YoY +16.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 29.4% · trend +3.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project VEEV's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

22%

Trailing 3-yr CAGR was 21.9%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$252.80
Total enterprise IV
$42.22B
Diluted shares
0.17B
Terminal PV
$32.46B (77% of total)
Year-5 FCF
$3.82B
YearProjected FCFDiscounted PV
+1$1.73B$1.57B
+2$2.11B$1.74B
+3$2.57B$1.93B
+4$3.14B$2.14B
+5$3.82B$2.37B
Terminal$52.27B$32.46B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Stock-based comp (TTM)
$473M
non-cash dilution

Balance sheet · 2026-01-31

latest filed snapshot
Total assets
$8.98B
everything owned
Total liabilities
$1.76B
everything owed
Stockholders' equity
$7.21B
shareholder claim

Recent performance · 57 quarters

Revenue↑+16.0% +$115M
$836M
Net Income↑+24.8% +$49M
$244M
Free Cash Flow↑+53.6% +$37M
$107M
Operating Margin↑+3.3pts
29.4%

Drill down